Bliss GVS Pharma's Stock Surges, Outperforms Sector by 5.06% in Last 6 Days
Bliss GVS Pharma, a smallcap pharmaceutical company, has seen a surge in its stock price, hitting a 52-week high of Rs. 151.35 on November 28, 2024. The stock has outperformed its sector by 5.06% and gained 24.62% in the last 6 days. It is currently trading higher than its moving averages, indicating a positive trend. With a focus on affordable and quality healthcare products, the company is poised for growth in the future.
Bliss GVS Pharma, a smallcap pharmaceutical company, has recently seen a surge in its stock price, hitting a 52-week high of Rs. 151.35 on November 28, 2024. The stock has been performing well in the market, outperforming its sector by 5.06% and gaining 24.62% in the last 6 days.
The stock opened with a gain of 3.42% today and touched an intraday high of Rs. 151.35, showing a consecutive gain for the last 6 days. Bliss GVS Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market.
In comparison to the Sensex performance of 21.19%, Bliss GVS Pharma has shown a 1-year performance of 5.76%. This smallcap company has been gaining traction in the market, with its stock call being 'Hold' by MarketsMOJO.
Bliss GVS Pharma is a pharmaceutical company that focuses on providing affordable and quality healthcare products to its customers. With its recent surge in stock price and positive market performance, the company is poised for growth in the future. Investors can keep an eye on this smallcap company as it continues to make strides in the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
